Attracting investments is one of the priorities in the activities of the Unified Distributor. Today, there is increased interest in the domestic pharmaceutical market from international investors, who are looking for new opportunities in emerging markets.
The head of state emphasized the significance of cooperation with global pharmaceutical corporations, attracting investors, ensuring the transfer of technology and the latest developments.
The unified distributor is taking the initiative to provide a platform for large brands to enter the country covering the entire production cycle from packaging to full production. Thanks to an integrated and systematic approach, there are already positive results in this direction.
For example, the unified distributor has entered into historical long-term agreements with pharmaceutical giants Roche and Pfizer for the contract production of original innovative drugs. Along with this, Kazakhstan has established agreements with Johnson & Johnson LLC, AstraZeneca and Bayer KAZ LLP for the development of contract manufacturing of medicines and technology transfer in the field of clinical trials.
Thus, there is an active process of relocating offices of global industry players to Kazakhstan. Such a significant step plays an important role in establishing a domestic and promising infrastructure with the possibility of conducting clinical trials, creating R&D centers and improving the country's human resources potential.
To further develop contract manufacturing and attract investments from global players in Kazakhstan, the unified distributor SK-Pharmaceuticals LLP and the Astana International Financial Centre (AIFC) entered into a Memorandum of Understanding.
Cooperation with the AIFC opens up new opportunities for the company’s development, as it is a leading financial centre in the Central Asia and Eastern Europe region, which enhances Kazakhstan’s investment attractiveness by providing foreign investors with a reliable legal framework, an independent judicial system, developed financial infrastructure, innovation and expertise.
The activities of AIFC participants are regulated in accordance with the AIFC Acts, which are based on the principles, norms and precedents of the law of England and Wales, and the standards of the world's leading financial centres.
By attracting BigPharma to the domestic market through the localization ofproduction, as well as their offices, Kazakhstan is getting closer to creating a solid infrastructure for a pharmaceutical hub, which will serve as a platform for the distribution of medicines and medical products to countries both nearby and far abroad.
“This approach will have a positive impact on the creation of pharmaceutical hubs in the country. It is known that as part of the development of Kazakhstan as a trade and logistics hub, the creation of a pharmaceutical logistics hub in Central Asia has been initiated. First of all, this is necessary for the rapid and efficient distribution of medicines,” noted Erkhat Iskaliev, Chairman of the management Board of SK-Pharmaceuticals LLP.
In pursuance of the President’s instructions on the development of a trade and transport hub in Kazakhstan with the industrialization of product groups, the warehouse and transport logistics system, The Unified Distributor became part of this grand project, being the anchor client of the pharmaceutical hub.
“The AIFC offers foreign investors a predictable and familiar legal environment, as along with a comprehensive ecosystem of financial services essential for a comfortable business environment. This agreement will establish the foundation for cooperation on the AIFC platform in developing investment projects aimed at advancing the pharmaceutical industry and attracting foreign pharmaceutical companies. In addition, the signed Memorandum will facilitate the establishment of contacts and exchange of experience,” noted Temirlan Mukhanbetzhanov, Acting Chairman of the management Board of the AIFC Authority.
Thus, the purpose of the Memorandum is to provide a common framework for cooperation on issues of mutual interest. The document outlines collaborative efforts to coordinate practical activities defining the directions and forms of interaction between the parties.
At the end of the meeting, the parties expressed their readiness for close fruitful cooperation with the prospect of expanding the Kazakh market and strengthening a mutually beneficial partnership. The importance of consolidating joint efforts to achieve effective indicators of industry development was emhasized.
